Gene Query: EPHA1

Dataset Description Geneva Score
RNA sequencing analysis of human embryonic stem cells and axial progenitors 114.49
RNA-seq analysis of RALD iPSCs after in vitro differentiation 51.34
RNA-Seq from early time points in the kidney differentiation protocol 49.98
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 47.77
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 44.79
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 43.79
CD95/Fas ligand mRNA is toxic to cells 41.6
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 40.2
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 40.2
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 39.88
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 38.03
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 37.93
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 37.92
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 36.86
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 36.56
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 36.18
MARS Seq data from human cortical organoids 35.62
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 34.74
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 33.53
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 30.64
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 30.23
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 30.02
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 28.68
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 28.29
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 26.59
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 26.23
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 26.18
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 25.84
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 25.09
Transcriptome analysis of H9 hESC derived cerebral organoids 25.05
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 24.6
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 24.46
Lineage specific differentiation is influenced by state of human pluripotency 24.32
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 24.32
Differentially expressed vascular development genes for iPSC-ECs from CDI 24.31
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 23.72
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 23.43
RNA-seq of YB5 cells treated with Proscillaridin A 22.34
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 21.94
Dynamic reorganization of nuclear architecture during human cardiogenesis 21.94
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 21.8
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 21.54
Cerebellar differentiation in Ataxia-Telangiectasia 21.32
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 20.99
High-efficiency RNA-based reprogramming of human primary fibroblasts 20.81
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 20.28
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 20.28
Ectoderm specification of H1 human embryonic stem cells 20.0
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 19.77
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 19.77
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 19.64
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 19.64
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 18.8
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 18.7
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 18.65
Expression profiles of the four human major ectodermal lineages 18.46
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 18.14
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 18.14
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 18.06
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 18.03
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 17.94
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 17.94
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 17.27
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 17.18
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 17.04
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 17.04
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 16.84
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 16.72
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 16.6
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 16.57
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 16.2
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 15.86
iPSC-Derived Cholangiocytes 15.57
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 15.57
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 15.55
WRN knockout effects upon gene expression in SW48 and OVK18 15.49
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 15.29
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 15.29
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 15.27
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 14.8
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 14.73
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 14.53
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 14.4
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 14.32
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 14.17
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 14.04
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 14.03
Engineering Patient-Specific Tissue Implants 13.93
Mechanistic Model-Guided Study of Embryonic Morphogenesis 13.78
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 13.76
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 13.52
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 13.49
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 13.19
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 13.04
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 12.89
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 12.87
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 12.84
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 12.84
RNA-seq of naive and primed ES cells (NHSM) 12.74
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 12.68
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.28
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.28
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 12.0
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 11.95
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 11.84
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 11.84
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 11.75
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 11.58
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 11.34
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 11.17
BI Human Reference Epigenome Mapping Project 11.12
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 11.09
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 10.94
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 10.94
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.92
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 10.92
DRB/GRO-Seq -/+ UV 10.74
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 10.58
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 10.51
NR2F2 study 10.51
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 10.51
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 10.37
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 10.32
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 10.29
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 10.29
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 10.08
BAF controls genome accessibility 10.03
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 9.88
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 9.86
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.74
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 9.46
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 9.35
hESC neural differentiation 9.32
RNA-seq analysis of gene expression patterns during hESC neural differentiation 9.32
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 9.27
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 9.2
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.18
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 9.1
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.91
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 8.88
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.84
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.84
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 8.82
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 8.77
RNA-seq of naive and primed ES cells 8.75
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 8.72
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 8.72
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 8.6
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 8.6
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.55
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 8.49
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.47
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 8.44
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 8.24
Examining serotonergic neuron differentiation from human iPSCs 8.16
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 8.08
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 8.08
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 8.01
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 7.99
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 7.92
Derivation and differentiation of haploid human embryonic stem cells 7.62
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 7.59
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.55
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.55
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 7.52
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.52
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 7.51
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 7.42
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.36
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 7.31
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 7.31
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.31
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.31
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 7.24
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 7.11
AMPK signaling for naïve pluripotency 7.04
AMPK signaling for naïve pluripotency [Hs] 7.04
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.98
Proliferation-correlated expression 6.96
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 6.87
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.73
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 6.69
FGF2 regulation of gene expression in stable inducible Neurons 6.69
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 6.69
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 6.64
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.6
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 6.52
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.47
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 6.37
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.28
Next Generation Sequencing of human SMA and healthy control Motor Neurons 6.27
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 6.23
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 6.22
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 6.21
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 6.15
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 6.12
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.1
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 6.08
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 6.03
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.0
circRNA profile in hypopharyngeal cancer 5.89
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 5.85
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.64
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 5.6
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 5.55
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.53
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 5.49
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 5.49
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.47
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.43
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 5.41
RNA-Seq from human ILC transitional populations 5.41
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.41
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 5.36
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 5.35
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.3
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.3
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.28
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 5.19
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 5.19
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 5.17
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.04
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 5.04
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 5.02
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.0
Generation of KRAS signatures using immortalized isogenic lung cells. 4.98
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 4.89
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.86
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.86
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.86
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.85
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.85
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 4.85
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 4.85
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.84
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 4.83
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 4.8
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 4.8
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.79
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.72
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.68
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 4.68
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 4.67
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.67
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.62
RNA-seq of human aneuploid cell lines with Trisomy 21 4.6
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.52
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 4.48
High-throughput sequencing of pluripotent cells 4.43
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.39
4.38
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 4.37
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.34
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 4.31
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.28
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.27
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 4.26
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 4.26
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.26
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 4.21
Functional Haploid Human Oocytes Generated from Polar Body Genomes 4.21
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.2
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 4.2
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.13
Postnatal lipids drive hepatocyte maturation 4.1
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 4.1
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.09
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.09
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.07
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.05
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 4.05
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.02
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.02
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.01
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.01
Transcriptomic and gene ontology profiling of the human corneal cell types 3.99
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 3.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.84
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.77
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.77
Stem and effector CD8 T-cells from human cancers 3.76
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.75
Identifying the molecular mode of action of itraconazole in colorectal cancer 3.75
Transcriptome of EBV-infected gastric cancer cell lines 3.71
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 3.67
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 3.67
RNA Seq of Alagille liver biopsies 3.65
Alagille_Nodder 3.65
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 3.65
RNA-seq differential expression studies: more sequence, or more replication? 3.63
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.62
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.61
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.57
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.56
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 3.55
Transcriptome of activated human and mouse MAIT cells 3.54
MEIS1 regulates hematopoiesis in hPSCs 3.51
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.48
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.48
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.47
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 3.45
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.43
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.43
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.42
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.39
Human embryonic stem cells in E8 and AKIT culture medium 3.39
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.39
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.39
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.35
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 3.26
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 3.24
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 3.24
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.24
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.15
RNA-sequencing in immortalized human mammary epithelial cells 3.15
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.12
Recovery and analysis of nascent RNA 3.11
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.11
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.11
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.1
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 3.09
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 3.09
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.07
Global expression profiles in cardiac progenitor cells generated by ISX-9 3.05
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 3.05
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.04
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.03
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.03
Epigenome regulation during epidermal lineage commitment 3.02
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.99
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.98
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.97
4sU-seq of HFF exposed to salt and heat stress 2.97
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.96
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.86
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  2.84
Noncoding regions are the main source of targetable tumor-specific antigens 2.83
Evaluating pre-clinical models for studying NASH driven HCC. 2.82
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.81
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.7
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 2.69
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.69
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.69
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 2.69
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 2.69
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 2.68
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.63
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.59
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.58
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.57
Paxillin regulates genomic networks in prostate cancer [PC3] 2.54
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.54
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.52
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.52
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.51
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.49
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.49
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.46
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.46
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.33
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.33
DIGIT regulates endoderm differentiation of human embryonic stem cells 2.27
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.27
Microglia innatly develop within cerebral organoids 2.25
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.25
Investigate A2M treatment on human prostate cancer xenograft in mice 2.21
Investigate A2M treatment on human prostate cancer and mouse liver 2.21
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 2.2
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 2.18
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.15
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.15
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.14
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.12
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.12
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.11
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 2.05
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.05
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.03
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.03
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.03
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.99
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 1.96
CSL 1.96
CSL RNA-Seq on HKC and SCC cell lines 1.96
RNA-sequencing 1.96
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.91
Gene expression analysis of human adenomas. 1.91
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.91
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.86
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 1.86
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 1.86
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.83
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.83
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.82
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.76
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.75
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.68
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.68
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.65
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.58
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.56
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.52
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.46
The circadian transcriptional landscape in primary human mammary epithelial cells 1.41
RNA sequencing of human pancreatic cancer cell lines 1.4
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.34
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 1.33
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.32
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.32
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.29
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.29
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.27
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.21
Molecular Criteria for Defining the Naive Human Pluripotent State 1.19
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 1.18
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.14
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.12
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.1
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.1
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.1
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.1
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.1
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.08
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.06
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.04
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.03
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.0
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.0
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.0
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 0.97
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.97
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.96
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.93
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.92
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.9
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.9
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.86
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.84
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.82
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 0.81
The expression profiles of GBC liver metastasis 0.8
Total RNA sequencing of APC mutant and wt colonic organoids 0.79
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.78
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.78
MRTF activates TEAD-YAP target gene expression 0.77
Identification of long noncoding RNAs regulated by p53 0.74
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.73
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.71
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.71
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.71
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.69
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.66
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.61
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.61
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.58
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.56
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.54
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.53
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.52
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.5
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.48
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.43
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.42
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.41
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.41
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.39
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.36
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.36
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.35
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.33
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.33
Gene expression analysis of breast cancer cell-lines 0.33
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.33
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.32
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.32
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.29
BASP1 modifies the Tamoxifen response 0.29
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.28
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.28
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.27
ML29755 RNA-seq data 0.26
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.24
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.23
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.22
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.18
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.17
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.16
p63 controls the enhancer landscape during keratinocyte differentiation 0.1
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.09
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.08
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.05
UV_24h_GRO-Seq 0.0
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation